机译:Real-B(来自亚太地区肝脏联盟的现实世界效力为HBV) - 慢性肝炎(CHB)患者中肝细胞癌(HCC)预测的风险评分,抗HBV治疗治疗
Stanford Univ Palo Alto CA 94304 USA;
Genom Res Ctr Taipei Taiwan;
Kaohsiung Med Univ Hepatobilary Div Dept Internal Med Kaohsiung Taiwan;
Med &
Therapeut Inst Digest Dis Kaohsiung Taiwan;
China Med Univ Hosp Div Hepatogastroenterol Dept Internal Med Taichung Taiwan;
Chang Gung Mem Hosp Kaohsiung Med Ctr Kaohsiung Taiwan;
San Jose Gastroenterol San Jose CA USA;
Univ Hong Kong Dept Med Hong Kong Hong Kong Peoples R China;
Natl Taiwan Univ Coll Med Grad Inst Clin Med Taipei Taiwan;
Osaka City Univ Grad Sch Med Hepatol Osaka Japan;
Kyushu Univ Hosp Fukuoka Japan;
Palo Alto Med Fdn Mountain View CA USA;
Chinese Hosp &
Clin Daly City CA USA;
Sutter Hlth Christopher Wong Inc San Francisco CA USA;
Sutter Hlth Clifford Wong Inc San Francisco CA USA;
Auckland City Hosp Liver Transplant Unit Auckland New Zealand;
Stanford Univ Palo Alto CA 94304 USA;
China Med Univ Hosp Div Hepatogastroenterol Dept Internal Med Taichung Taiwan;
Yamagata Univ Fac Med Yamagata Japan;
Auckland City Hosp Liver Transplant Unit Auckland New Zealand;
Capital Med Univ Beijing Ditan Hosp Liver Dept Beijing Peoples R China;
Kyushu Univ Hosp Fukuoka Japan;
Osaka City Univ Grad Sch Med Hepatol Osaka Japan;
Natl Taiwan Univ Coll Med Grad Inst Clin Med Taipei Taiwan;
Univ Hong Kong Dept Med Hong Kong Hong Kong Peoples R China;
Kaohsiung Med Univ Dept Internal Med Heptobiliary Div Kaohsiung Taiwan;
机译:Real-B(来自亚太地区肝脏联盟的现实世界效力为HBV) - 慢性肝炎(CHB)患者中肝细胞癌(HCC)预测的风险评分,抗HBV治疗治疗
机译:亚太地区肝脏联盟对HBV风险评分的真实效力,用于预测口腔抗病毒治疗慢性乙型肝炎患者肝细胞癌的肝细胞癌
机译:来自亚太地区肝脏联盟的现实世界效力,用于预测口腔抗病毒治疗慢性乙型肝炎患者肝细胞癌预测的HBV风险评分
机译:慢性丙型肝炎患者的BERATROPHIN表达:是否有助于肝损伤链接代谢综合征和肝细胞癌发育?
机译:恩替卡韦治疗亚洲慢性乙型肝炎患者的肝细胞癌风险预测模型
机译:慢性乙型肝炎肝胆癌风险估算(REACH-B)评分在亚太地区肝(APASL)慢性乙型肝炎患者肝(APASL)指南下的肝硬化协会中的评分